PHARMACOKINETIC COMPARISON BETWEEN FIXED DOSE COMBINATION OF FIMASARTAN/AMLODIPINE/HYDROCHLOROTHIAZIDE 60/10/25 MG AND CORRESPONDING LOOSE COMBINATION.

被引：0
|
作者：
Lee, S. [1 ]
Lee, S. [1 ]
Yoo, H. [1 ]
Jeon, I. [1 ]
Na, J. [1 ]
Jang, I. [1 ]
Yu, K. [1 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
E-007
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [41] FIXED-DOSE COMBINATION THERAPY WITH TELMISARTAN AND AMLODIPINE 5 MG IN NON-RESPONDERS TO AMLODIPINE 5 MG PROVIDES SUPERIOR BLOOD PRESSURE REDUCTIONS TO, AND IS BETTER TOLERATED THAN, AMLODIPINE 10 MG
    Neldam, S.
    Lang, M.
    JOURNAL OF HYPERTENSION, 2009, 27 : S273 - S274
  • [42] Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20 mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use (vol 34, pg 1, 2018)
    Lyseng-Williamson, Katherine A.
    DRUGS & THERAPY PERSPECTIVES, 2018, 34 (07)
  • [43] A PHARMACOKINETIC COMPARISON BETWEEN FIXED-DOSE COMBINATION AND SEPARATE TABLETS OF ROSUVASTATIN AND METFORMIN IN FED STATE AND FOOD EFFECT OF FIXED-DOSE COMBINATION IN HEALTHY SUBJECTS.
    Kim, E.
    Rhee, S-J.
    Kim, Y.
    Oh, J.
    Suh, H.
    Lee, Y.
    Lee, Y.
    Cho, J-Y.
    Yu, K-S.
    Lee, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S40 - S40
  • [44] Effect of the fixed combination of irbesartan 300 mg/hydrochlorothiazide 25 mg on the circadian blood pressure profile in essential hypertension
    Coca, A
    Calvo, C
    Sabrino, J
    Sierra, C
    López-Paz, JE
    Gómez-Angelats, E
    Bragulat, E
    de la Sierra, A
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 189A - 189A
  • [45] Investigation of bioequivalence, safety, and tolerability of a fixed-dose combination of nifedipine GITS and candesartan compared with the corresponding loose-dose combination under fed conditions
    Thomas, Dirk
    Liu, Yuwang
    Stein, Herbert
    Weimann, Boris
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (08) : 420 - 428
  • [46] Pharmacokinetics of a telmisartan, amlodipine and hydrochlorothiazide fixed-dose combination: A replicate crossover study in healthy Korean male subjects
    Lee, Sang Young
    Kang, Kkot Nim
    Kang, Jae Hoon
    Jeong, Kyu Ho
    Lee, Sang Won
    Park, Hye Kyung
    Lee, Eui-Kyung
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (09) : 2245 - 2253
  • [47] SWITCH TO A FIXED-DOSE COMBINATION THERAPY WITH TELMISARTAN AND AMLODIPINE PROVIDES SIGNIFICANT BLOOD PRESSURE REDUCTION AND CONTROL IN PATIENTS NOT ADEQUATELY CONTROLLED WITH AMLODIPINE 10 MG
    Neldam, S.
    Edwards, C.
    JOURNAL OF HYPERTENSION, 2009, 27 : S277 - S277
  • [48] Pharmacokinetic and Pharmacodynamic Profiles of a Fixed-Dose Combination of Olmesartan Medoxomil and Amlodipine in Healthy Chinese Males and Females
    Xia Chen
    Pei Hu
    Ji Jiang
    Tao Liu
    Wen Zhong
    Hongzhong Liu
    Qian Zhao
    Clinical Drug Investigation, 2012, 32 : 783 - 790
  • [49] Pharmacokinetic and Pharmacodynamic Profiles of a Fixed-Dose Combination of Olmesartan Medoxomil and Amlodipine in Healthy Chinese Males and Females
    Chen, Xia
    Hu, Pei
    Jiang, Ji
    Liu, Tao
    Zhong, Wen
    Liu, Hongzhong
    Zhao, Qian
    CLINICAL DRUG INVESTIGATION, 2012, 32 (12) : 783 - 790
  • [50] Adherence to Oral Antidiabetic Agents with Pioglitazone and Metformin: Comparison of Fixed-Dose Combination Therapy with Monotherapy and Loose-Dose Combination Therapy
    Barner, Jamie C.
    CLINICAL THERAPEUTICS, 2011, 33 (09) : 1281 - 1288
12345